Hims & Hers Shows It’s More Than Just GLP-1 Drugs

247wallst.com/investing/2025/05/07/hims-hers-shows-its-more-than-just-glp-1-drugs

24/7 Wall St. Insights:




Hims & Hers Health (HIMS) released first-quarter earnings after the closing bell on Monday and saw shares surge on the robust numbers.



HIMS stock jumped 18% on Tuesday after revenue doubled, profit surged, and new subscribers roared higher.


This story appeared on 247wallst.com, 2025-05-07 12:54:39.
The Entire Business World on a Single Page. Free to Use →